Fengying Y. Guan

Changchun, 130021, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

miR-27a Suppresses Mitochondrial Function to Promote Hepatic Steatosis in High-Fat-Diet-Induced Obesity.

miR-27a Suppresses Mitochondrial Function to Promote Hepatic Steatosis in High-Fat-Diet-Induced Obesity.

Journal: Molecules (Basel, Switzerland)

Published: April 21, 2026

Lactate links exercise to synaptic protection and cognitive enhancement in Alzheimer's disease models.

Lactate links exercise to synaptic protection and cognitive enhancement in Alzheimer's disease models.

Journal: BMC medicine

Published: March 18, 2025

Effects of (20 R)-Panaxadiol on NAFLD using non‑targeted metabolomics in stool.

Effects of (20 R)-Panaxadiol on NAFLD using non‑targeted metabolomics in stool.

Journal: Journal of pharmaceutical and biomedical analysis

Published: May 09, 2023

Berberine mitigates hepatic insulin resistance by enhancing mitochondrial architecture via the SIRT1/Opa1 signalling pathway.

Berberine mitigates hepatic insulin resistance by enhancing mitochondrial architecture via the SIRT1/Opa1 signalling pathway.

Journal: Acta biochimica et biophysica Sinica

Published: October 21, 2022

(20R)-panaxadiol improves obesity by promoting white fat beigeing.

(20R)-panaxadiol improves obesity by promoting white fat beigeing.

Journal: Frontiers in pharmacology

Published: October 16, 2022

(20R)-Panaxadiol as a Natural Active Component with Anti-Obesity Effects on ob/ob Mice via Modulating the Gut Microbiota.

(20R)-Panaxadiol as a Natural Active Component with Anti-Obesity Effects on ob/ob Mice via Modulating the Gut Microbiota.

Journal: Molecules (Basel, Switzerland)

Published: March 13, 2022

Analysis of Serum Metabolomics in Rats with Osteoarthritis by Mass Spectrometry.

Analysis of Serum Metabolomics in Rats with Osteoarthritis by Mass Spectrometry.

Journal: Molecules (Basel, Switzerland)

Published: October 29, 2021

A New Berberine Preparation Protects Pancreatic Islet Cells from Apoptosis Mediated by Inhibition of Phospholipase A2/p38 MAPK Pathway.

A New Berberine Preparation Protects Pancreatic Islet Cells from Apoptosis Mediated by Inhibition of Phospholipase A2/p38 MAPK Pathway.

Journal: Bulletin of experimental biology and medicine

Published: June 08, 2021

Berberine Inhibits the Apoptosis-Induced Metastasis by Suppressing the iPLA2/LOX-5/LTB4 Pathway in Hepatocellular Carcinoma.

Berberine Inhibits the Apoptosis-Induced Metastasis by Suppressing the iPLA2/LOX-5/LTB4 Pathway in Hepatocellular Carcinoma.

Journal: OncoTargets and therapy

Published: December 22, 2019

Highly bioavailable berberine formulation ameliorates diabetic nephropathy through the inhibition of glomerular mesangial matrix expansion and the activation of autophagy.

Highly bioavailable berberine formulation ameliorates diabetic nephropathy through the inhibition of glomerular mesangial matrix expansion and the activation of autophagy.

Journal: European journal of pharmacology

Published: November 06, 2019

Gene knockout technology and its application in the study of the relationship between mitochondrial dynamics and insulin resistance

Gene knockout technology and its application in the study of the relationship between mitochondrial dynamics and insulin resistance

Journal: Sheng wu gong cheng xue bao = Chinese journal of biotechnology

Published: August 24, 2019

Highly bioavailable Berberine formulation improves Glucocorticoid Receptor-mediated Insulin Resistance via reduction in association of the Glucocorticoid Receptor with phosphatidylinositol-3-kinase.

Highly bioavailable Berberine formulation improves Glucocorticoid Receptor-mediated Insulin Resistance via reduction in association of the Glucocorticoid Receptor with phosphatidylinositol-3-kinase.

Journal: International journal of biological sciences

Published: August 20, 2019

Showing 1-12 of 21

Last Updated: 09/26/2026